Xiaofei Wei
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 10%
- Immune Cell Function and Interaction
Papers in
- Oncology 11
- CAR-T cell therapy research 7
- Cancer Cells and Metastasis 2
-
- CRISPR and Genetic Engineering 3
- Co-authors
- Haoyi Wang (6 shared papers)Xingying Zhang (3 shared papers)Na Li (3 shared papers)Wei Mu (2 shared papers)Na Tang (5 shared papers)Weidong Han (3 shared papers)Miaomiao Qiao (2 shared papers)Chen Cheng (1 shared paper)
- Journals
- Oncotarget (2 papers)Journal of Asian Natural Products Research (1 paper)Acta Neuropathologica Communications (1 paper)College & Research Libraries (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaofei Wei
28 papers receiving 1.1k citations
Xiaofei Wei's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 689
- Immunology 247
- Cancer Research 171
- Molecular Biology 536
- Genetics 217
Countries citing papers authored by Xiaofei Wei
This map shows the geographic impact of Xiaofei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Wei more than expected).
Fields of papers citing papers by Xiaofei Wei
This network shows the impact of papers produced by Xiaofei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Wei. The network helps show where Xiaofei Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors Hit paper breakdown → | 2020 | 293 |
| 2 | 2017 | 191 | |
| 3 | 2014 | 136 | |
| 4 | 2008 | 130 | |
| 5 | 2022 | 99 | |
| 6 | 2015 | 68 | |
| 7 | 2020 | 44 | |
| 8 | 2015 | 44 | |
| 9 | 2018 | 21 | |
| 10 | 2010 | 19 | |
| 11 | 2014 | 11 | |
| 12 | 2024 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2008 | 8 | |
| 15 | 2012 | 7 | |
| 16 | 2024 | 5 | |
| 17 | 2019 | 5 | |
| 18 | 2019 | 2 | |
| 19 | 2020 | 2 | |
| 20 | [Effects of whole body vibration on structural and functional remodeling of subchondral bones in rabbits with early osteoarthritis]. | 2014 | 2 |
About Xiaofei Wei
Xiaofei Wei is a scholar working on Oncology, Molecular Biology, Plant Science, Genetics and Cancer Research, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers), Nanowire Synthesis and Applications (3 papers), Mesenchymal stem cell research (2 papers), Plant nutrient uptake and metabolism (2 papers), Cancer Cells and Metastasis (2 papers) and Rice Cultivation and Yield Improvement (2 papers). The work is most often cited by research in Oncology (689 citations), Immunology (247 citations), Cancer Research (171 citations), Molecular Biology (536 citations) and Genetics (217 citations). Xiaofei Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Haoyi Wang, Xingying Zhang, Na Li, Wei Mu, Na Tang, Weidong Han, Miaomiao Qiao, Chen Cheng, Chen Cheng and Hao Zhang. Their work appears in journals such as Oncotarget, Journal of Asian Natural Products Research, Acta Neuropathologica Communications, College & Research Libraries and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.